Cantor Fitzgerald Increases Lam Research (NASDAQ:LRCX) Price Target to $170.00

Key Points

• Cantor Fitzgerald has increased its price target for Lam Research (NASDAQ:LRCX) from $155.00 to $170.00, indicating a potential upside of 24.56% from the stock's previous close.
• The semiconductor company received upgrades from multiple analysts, with a consensus rating of "Moderate Buy" and an average target price of $123.80.
• Lam Research's quarterly earnings surpassed expectations, reporting $1.33 earnings per share and a revenue of $5.17 billion, marking a 33.6% increase compared to the same quarter last year.

Lam Research (NASDAQ:LRCX - Get Free Report) had its target price hoisted by equities research analysts at Cantor Fitzgerald from $155.00 to $170.00 in a note issued to investors on Tuesday,MarketScreener reports. The brokerage currently has an "overweight" rating on the semiconductor company's stock. Cantor Fitzgerald's target price indicates a potential upside of 24.56% from the stock's previous close.

Other analysts have also recently issued reports about the company. Hsbc Global Res upgraded Lam Research to a "hold" rating in a research report on Tuesday, September 30th. Wall Street Zen upgraded shares of Lam Research from a "hold" rating to a "buy" rating in a research note on Saturday, October 4th. The Goldman Sachs Group raised their price objective on shares of Lam Research from $115.00 to $160.00 and gave the stock a "buy" rating in a report on Wednesday, October 8th. Oppenheimer upped their target price on shares of Lam Research from $110.00 to $120.00 and gave the company an "outperform" rating in a research note on Thursday, July 31st. Finally, Raymond James Financial increased their target price on Lam Research from $90.00 to $110.00 and gave the stock an "outperform" rating in a report on Thursday, July 31st. Twenty-three investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $123.80.

Lam Research Price Performance

Shares of NASDAQ:LRCX opened at $136.48 on Tuesday. The company has a market cap of $172.10 billion, a price-to-earnings ratio of 32.86, a PEG ratio of 1.60 and a beta of 1.84. The business has a 50 day moving average price of $115.59 and a 200 day moving average price of $95.18. The company has a quick ratio of 1.55, a current ratio of 2.21 and a debt-to-equity ratio of 0.38. Lam Research has a twelve month low of $56.32 and a twelve month high of $153.70.

Lam Research (NASDAQ:LRCX - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.12. The company had revenue of $5.17 billion during the quarter, compared to analysts' expectations of $4.99 billion. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.Lam Research's revenue for the quarter was up 33.6% compared to the same quarter last year. During the same period in the prior year, the business earned $1.03 earnings per share. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Research analysts predict that Lam Research will post 3.71 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in LRCX. Smallwood Wealth Investment Management LLC bought a new stake in shares of Lam Research in the 1st quarter valued at about $26,000. IMG Wealth Management Inc. acquired a new stake in Lam Research in the second quarter worth $26,000. Howard Hughes Medical Institute bought a new position in shares of Lam Research during the second quarter worth $27,000. Strategic Wealth Investment Group LLC bought a new stake in shares of Lam Research in the 2nd quarter valued at $29,000. Finally, Delos Wealth Advisors LLC acquired a new stake in Lam Research during the 2nd quarter worth $30,000. 84.61% of the stock is currently owned by institutional investors.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.